Last Close
Jun 18  •  11:08AM ET
95.75
Dollar change
+0.81
Percentage change
0.85
%
Index
RUT
P/E
79.29
EPS (ttm)
1.21
Insider Own
3.22%
Shs Outstand
5.52M
Perf Week
-10.80%
Market Cap
529.04M
Forward P/E
7.75
EPS next Y
12.36
Insider Trans
2.08%
Shs Float
5.35M
Perf Month
-4.08%
Enterprise Value
670.94M
PEG
-
EPS next Q
2.62
Inst Own
87.65%
Perf Quarter
16.04%
Income
6.71M
P/S
2.12
EPS this Y
3.24%
Inst Trans
1.30%
Perf Half Y
21.78%
Sales
249.13M
P/B
2.84
EPS next Y
4.92%
ROA
1.56%
Perf YTD
21.98%
Book/sh
33.71
P/C
19.64
EPS next 5Y
-
ROE
3.88%
52W High
113.99 -16.00%
Perf Year
2.97%
Cash/sh
4.87
P/FCF
13.37
EPS past 3/5Y
90.85% 13.55%
ROIC
1.94%
52W Low
55.45 72.69%
Perf 3Y
-29.36%
EV/EBITDA
16.06
Sales past 3/5Y
4.38% 13.22%
Gross Margin
56.56%
Volatility
6.25% 7.15%
Perf 5Y
-63.20%
EV/Sales
2.69
EPS Y/Y TTM
445.05%
Oper. Margin
7.43%
ATR (14)
6.06
Perf 10Y
-21.69%
Quick Ratio
1.29
Sales Y/Y TTM
3.38%
Profit Margin
2.69%
RSI (14)
41.24
Current Ratio
1.72
EPS Q/Q
42.97%
SMA20
-7.98%
Beta
0.93
Debt/Eq
0.91
Sales Q/Q
2.56%
SMA50
-6.13%
Rel Volume
0.92
Prev Close
94.95
Employees
717
LT Debt/Eq
0.86
SMA200
12.69%
Avg Volume
159.25K
Price
95.75
IPO
Feb 29, 1984
Option/Short
No / Yes
Trades
Volume
42,166
Change
0.85%
Date Action Analyst Rating Change Price Target Change
Aug-07-25Upgrade Wells Fargo Underweight → Equal Weight $67
Aug-28-24Initiated Wells Fargo Underweight $120
Jan-04-24Upgrade Evercore ISI In-line → Outperform $100 → $125
Jan-04-21Downgrade Evercore ISI Outperform → In-line $300
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $287
Oct-02-20Initiated JP Morgan Neutral $260
Dec-04-19Initiated Jefferies Buy
Aug-26-19Initiated Evercore ISI Outperform $250
Jun-10-16Downgrade Sidoti Buy → Neutral
Jun-17-26 04:42AM
May-27-26 08:18AM
08:00AM
May-05-26 01:39PM
Apr-02-26 06:00PM
04:30PM Loading…
Mar-09-26 04:30PM
Feb-20-26 07:02AM
Feb-03-26 08:11AM
08:00AM
Jan-07-26 05:00PM
Dec-18-25 07:00PM
Dec-03-25 05:35PM
Nov-25-25 08:09AM
Nov-12-25 03:14PM
Nov-06-25 07:01PM
04:15PM Loading…
04:15PM
Oct-03-25 11:46AM
11:01AM
Sep-22-25 06:53AM
Sep-05-25 06:34PM
Aug-18-25 02:01PM
Aug-05-25 09:15AM
08:10AM
08:00AM
Jul-31-25 05:45PM
Jul-03-25 12:00PM
Jul-02-25 03:20PM
May-28-25 09:15AM
08:23AM
08:00AM
05:25PM Loading…
May-15-25 05:25PM
May-14-25 05:45PM
May-13-25 05:35PM
May-08-25 08:45AM
Apr-07-25 03:00PM
Apr-03-25 03:51PM
Mar-26-25 12:00PM
Feb-13-25 08:31AM
Feb-11-25 12:20PM
Feb-04-25 09:15AM
08:17AM
08:00AM
Jan-17-25 01:15PM
Jan-06-25 03:00PM
Nov-07-24 09:20AM
08:27AM
08:00AM
Oct-15-24 05:02PM
Oct-02-24 02:00PM
Aug-26-24 12:20PM
12:00PM
Aug-16-24 07:51AM
Aug-05-24 08:15AM
08:00AM
Jul-31-24 09:14AM
Jul-08-24 02:00PM
Jun-05-24 11:53AM
06:38AM
06:21AM
06:00AM
May-31-24 06:00AM
May-22-24 06:00AM
Apr-08-24 08:00AM
Apr-04-24 06:24PM
Apr-01-24 10:27AM
Mar-15-24 07:00AM
Feb-19-24 10:23AM
Feb-05-24 09:20AM
08:36AM
08:22AM
08:00AM
Jan-08-24 08:00AM
Jan-04-24 03:00PM
Jan-03-24 08:00AM
Dec-14-23 10:47AM
Nov-06-23 09:10AM
08:13AM
08:00AM
Oct-16-23 03:00AM
Oct-03-23 08:00AM
Sep-22-23 08:09AM
06:20AM
Sep-15-23 01:10AM
Sep-13-23 01:37PM
Sep-11-23 11:21AM
Aug-24-23 04:02PM
Aug-10-23 01:32AM
Aug-03-23 09:35AM
08:27AM
08:00AM
Jul-31-23 07:50AM
Jul-05-23 03:00PM
Jun-21-23 08:00PM
11:50AM
May-25-23 09:25AM
08:14AM
08:00AM
May-22-23 01:16PM
May-02-23 06:23AM
Apr-26-23 08:00PM
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
VPMr. John V. Sakys CPA
Senior Vice President of Continuous ImprovementMr. Brian David Archbold
M.S.Dr. Siddhartha Chandrakant Kadia B.E.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Archbold Brian DavidSVP OperationsJun 16 '26Sale101.271,151116,5583,710Jun 17 12:23 PM
Crennen Lyndsey ElizabethCAOJun 16 '26Sale101.2711811,9501,473Jun 17 12:19 PM
Sakys JohnCFOJun 16 '26Sale101.271,223123,85016,538Jun 17 12:09 PM
Archbold Brian DavidOfficerJun 16 '26Proposed Sale101.271,151116,558Jun 16 03:33 PM
Sakys JohnOfficerJun 16 '26Proposed Sale101.271,223123,850Jun 16 03:31 PM
Owens Gary MFormer OfficerJun 16 '26Proposed Sale101.273,706375,296Jun 16 03:29 PM
Archbold Brian DavidSVP OperationsJun 15 '26Option Exercise104.082,454255,4124,861Jun 16 02:44 PM
Sakys JohnCFOJun 15 '26Option Exercise104.082,717282,78517,761Jun 16 02:15 PM
Ladiwala Shiraz ShabanaliDirectorMar 10 '26Buy72.233,500252,8058,523Mar 10 05:43 PM
Capone Mark ChristopherDirectorMar 10 '26Buy76.351,30199,3313,429Mar 10 03:46 PM
Tripeny R TonyDirectorMar 10 '26Buy76.001,31599,9405,398Mar 10 03:39 PM
Owens Gary MPresident and CEOOct 27 '25Option Exercise0.0011,558064,135Oct 28 03:08 PM
Ladiwala Shiraz ShabanaliDirectorAug 15 '25Option Exercise0.001,94905,023Aug 18 02:37 PM
Sullivan John JamesDirectorAug 15 '25Option Exercise0.001,404027,282Aug 18 02:20 PM
Hall ShannonDirectorAug 15 '25Option Exercise0.001,40404,189Aug 18 02:02 PM
Tripeny R TonyDirectorAug 15 '25Option Exercise0.001,40404,083Aug 18 01:54 PM
Capone Mark ChristopherDirectorAug 15 '25Option Exercise0.001,40402,128Aug 18 01:45 PM
Alltoft Jennifer SadieDirectorAug 15 '25Option Exercise0.001,40404,878Aug 18 01:34 PM
Sakys JohnCFOJun 21 '25Option Exercise95.821,03699,27015,498Jun 25 09:14 AM
Archbold Brian DavidSVP OperationsJun 21 '25Option Exercise95.8284480,8722,792Jun 25 09:05 AM
Owens Gary MPresident and CEOJun 21 '25Option Exercise95.823,301316,30254,022Jun 24 10:12 AM